Dr. Anstey is a Professor of Psychology and Population Health at the Australian National University. She is Director of the Centre for Research on Ageing, Health and Wellbeing, and the Dementia Collaborative Research Centre - Early Diagnosis and Prevention. Her substantive research interests focus on the prevention of cognitive decline, cognitive impairment and dementia. Dr. Anstey has worked extensively with longitudinal studies and leads the PATH Through Life study, a 16-year population-based study of three cohorts, including over 7000 adults, spanning early to late adulthood. She is also involved in several non-pharmacological interventions to prevent cognitive decline and reduce risk of dementia, and conducts research to improve driving safety in older adults. Her team has developed screening tools for older drivers and is currently trialling interventions to improve driving skills on and off-road. Dr. Anstey is a Director of the Alzheimer’s Australia Dementia Research Foundation, a Member of the AARP Global Council on Brain Health, and a Panel Member of the Australian National Health and Medical Research Council Institute for Dementia Research.
Dr. Chertkow is a practicing cognitive neurologist at the Jewish General Hospital of McGill University in Montreal, where he helped found and direct Canada’s largest memory clinic. Dr. Chertkow’s major areas of research interest include early diagnosis of Alzheimer’s disease and prediction of deterioration in individuals with Mild Cognitive Impairment, the structure, organization, and function of the Semantic Memory component of long term memory and its deterioration in dementia, the localization of language and memory functions in the brain using functional imaging, and the therapy of anomia using neuromodulation approaches. Along with 270 publications including 170 peer-reviewed articles and chapters, Dr. Chertkow and his colleagues published the Montreal Cognitive Assessment in 2005. This is now used around the world to screen for cognitive loss in the elderly and has become an international standard for diagnosis of MCI. In 2014 Dr. Chertkow was elected to the Canadian Academy of Health Sciences. In addition, he is also the Scientific Director for the Canadian Consortium on Neurodegeneration in Aging.
Dr. Cummings leads the CLEAR Outcomes (Connecting Leadership Education & Research) research program in leadership science in health services, which focuses on the leadership practices of healthcare decision-makers and managers to achieve better outcomes for providers and patients. Dr. Cummings has systematically documented both positive and negative effects of specific leadership practices on outcomes for the health system, the healthcare workforce and for patients.
She has published over 150 papers in the past decade and in 2014 was noted by Thomson Reuters as a Highly Cited Researcher in Social Sciences. Dr. Cummings’ has received the Canadian Nurses Association Order of Merit for Research, and in 2015 was inaugurated into the Sigma Theta Tau International Nurse Researcher Hall of Fame.
Dr. Dixon is affiliated with the University of Alberta where he is Canada Research Chair (Tier 1) in Cognition and Aging, Professor of Psychology (Science), Director of the Victoria Longitudinal Study (VLS), and member of the Alberta Neuroscience and Mental Health Institute. He has held previous appointments at Max Planck Institute (Berlin) and University of Victoria (Canada), as well as several international guest positions. His recent recognitions include the 2013-14 Baltes Award for Distinguished Career Research in Aging (from the American Psychological Association) and two consecutive five-year terms as a National Institutes of Health (NIH) MERIT Award recipient. The VLS, which features an international team of collaborators and trainees, has been funded continuously for over 20 years by NIH (National Institute on Aging) and other sources. It is a large-scale, multi-cohort, epidemiological study of neurocognitive, biological, genetic, environmental, lifestyle, clinical, and health changes in aging. Current research emphases include examining dynamic, interactive, and synergistic functions of risk and protective biomarkers representing multiple domains associated with trajectories and transitions in healthy, normal, impaired, and neurodegenerative changes with aging.
Dr. Eskes is a clinical neuropsychologist and Professor in the Departments of Psychiatry, and Psychology & Neuroscience at Dalhousie University in Halifax, Nova Scotia. She received her Ph.D. in Psychology from the University of California at Berkeley and completed postdoctoral research and clinical training in Halifax as well as at the Rotman Research Institute at the Baycrest Centre for Geriatric Care in Toronto, Ontario. In addition to her clinical activities, Dr. Eskes is an active educator and researcher focused on mechanisms supporting cognitive health in normal aging, as well as those involved in recovery of function after stroke and in other forms of brain injury and disease. Dr. Eskes recently served as the working group co-chair for the latest Heart & Stroke Foundation Best Practices update on Vascular Cognitive Impairment. Her research has been funded by the Heart & Stroke Foundation, CIHR, NSERC, and Nova Scotia Health Research Foundation. Currently, she is the leader of a 5-year multi-disciplinary research project supported by the Atlantic Canada Opportunities Agency aimed at developing innovative cognitive repair technologies for stroke and Parkinson's disease.
Dr. Frayne is a Professor in the Departments of Radiology and Clinical Neuroscience, a member of the Hotchkiss Brain Institute and an associate member of the Libin Cardiovascular Institute of Alberta at the University of Calgary. He is also the Scientific Director of the Seaman Family Centre at the Foothills Medical Centre. Dr. Frayne’s research interests are in the development and application of new imaging techniques in humans for the study, detection and treatment of neurovascular disease. He is also interested in advanced image reconstruction and signal processing strategies as well as the imaging of concussion, and epilepsy. He holds a BASc in Electrical Engineering from the University of Waterloo and a PhD from the University of Western Ontario in Medical Biophysics. Dr. Frayne has over 20 years experience in pursuing imaging research in a clinical research environment. He has over 135 peer-reviewed publications, 20 international patents and had technology successfully commercialized. Dr. Frayne also directs the Calgary-based NSERC CREATE International and Industrial Imaging Training Program. In 2015 he received a 7-year Foundation Award from the CIHR to continue efforts in imaging aging, stroke, and small vessel disease.
Dr. Greenberg, Professor of Neurology at Harvard Medical School, holds the John J. Conway Endowed Chair in Neurology, directs the Hemorrhagic Stroke Research Program, and is Vice-Chair of Neurology for Faculty Development at the Massachusetts General Hospital. He has served in many national and international leadership roles in the fields of stroke and neurology including president of the International CAA Association, chair of the NIH Acute Neurologic Injury and Epilepsy grant review committee, session co-chair for the NINDS Alzheimer’s Disease-Related Dementias Summit, and chair of the American Heart Association International Stroke Conference. Dr. Greenberg has authored over 170 peer-reviewed research articles and over 60 chapters, reviews, and editorials in the areas of hemorrhagic stroke and small vessel brain disease. Dr. Greenberg received his undergraduate degree in Biochemistry from Harvard University and MD and PhD degrees from Columbia University under the graduate research training of Dr. James Schwartz. He performed internship at Pennsylvania Hospital, neurology residency at Massachusetts.
Dr. Hogan is an internal medicine specialist with additional training in geriatric medicine. At the University of Calgary, Dr. Hogan founded and was the inaugural Head of the Division of Geriatric Medicine. He holds the Brenda Strafford Foundation Chair in Geriatric Medicine at the University of Calgary and over the years has served as Chair of the Royal College of Physicians and Surgeons of Canada’s Specialty Committee in Geriatric Medicine, Chief Examiner in Geriatric Medicine for the RCPSC, President of the Canadian Geriatrics Society, President of a national network of dementia researchers, and editor of the Canadian Geriatrics Journal. Dr. Hogan has authored over 500 publications including approximately 250 peer-reviewed papers. His research interests include age-related cognitive decline and dementia and its causes. National awards he has received include the William B. Spaulding Award, the Irma M. Parhad Award, and the Prix d’excellence of the RCPSC. He has played a leadership role in a number of national initiatives such as the Canadian Consensus Conferences on the Assessment and Treatment of Dementia and the Canadian Consortium on Neurodegeneration in Aging. In 2011 he was appointed as the first Director of the Brenda Strafford Centre on Aging.
Dr. Holroyd-Leduc is an Associate Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary, Alberta, Canada. She received her medical degree and then completed residency training in Internal Medicine and Geriatrics at the University of Toronto, Ontario, Canada. She completed a research fellowship in Geriatrics and Quality Improvement as a VA Quality Scholar at the University of California, San Francisco, USA. Her research interests include knowledge synthesis and translation focused on improving care provided to older adults. She is the KT Chair of TVN (Technology Evaluation in the Elderly Network) NCE, an Associate Editor for the Canadian Medical Association Journal, and the previous Scientific Director of the Alberta Health Services Seniors Health Strategic Clinical Network.
Dr. Jhamandas is Distinguished University Professor in the Division of Neurology, Department of Medicine at the University of Alberta. He received his MSc in Biophysics from the University of Alberta and his MD from the University of Calgary. He completed his clinical training in Internal Medicine at the Toronto Western Hospital and in Neurology at the Montreal Neurological Institute. He received his PhD in Neuroscience from McGill University. Dr. Jhamandas’ research program focuses on studying misfolded proteins in Alzheimer's and Prion diseases and aspects of Brain control of cardiovascular function. His research has been funded by the CIHR, Heart and Stroke Foundation of Canada, and other national and provincial granting agencies. In recognition of his scholastic endeavors, he has received the Gold Medal in Medicine from the Royal College of Physicians and Surgeons of Canada; a Killam Professorship; the Department of Medicine Research Achievement
Award; held a Tier 1 Canada Research Chair in Alzheimer's Research, and has been
elected as a Fellow of the Canadian Academy of Health Sciences and the
merican Neurological Association.
Dr. Mitchell, a geriatrician and health services researcher, is a Professor of Medicine at Harvard Medical School and Senior Scientist at Hebrew Senior Life Institute for Aging Research in Boston. She graduated from the University of Ottawa Medical School, has a Master’s degree in Public Health from Harvard University, and is a member of the American Association of Physicians. Her research focuses on decision-making, outcomes, and resource utilization in advanced dementia. She has been the Principal Investigator on many NIH funded grants that aim to improve the cared provided to older patients with advanced illness and their families.
Dr. Moscovitch (BA, McGill; Ph.D., University of Pennsylvania; Post-doctoral, Montreal Neurological Institute) holds the Glassman Chair in Neuropsychology and Aging. He has been a senior scientist at the Rotman Research Institute since its inception in 1989, as well as a visiting professor at the Hebrew University, the Institute of Advanced Studies in Jerusalem, and the University of Arizona. Best known for his work on the cognitive and brain basis of memory, he also has made important contributions to research on face-recognition, attention, and hemispheric specialization in the healthy, aging and diseased brain. He has published over 300 papers, edited five books, and is one of the most cited psychologists in Canada. He is the recipient of lifetime achievement/distinguished career awards from the Canadian Society for Brain, Behaviour, Cognitive Science (Hebb Award, 2007), the Association for Psychological Science (William James Award, 2008), the Cognitive Neuroscience Society (2012), the International Neuropsychological Society (2012), and the Israeli Neuropsychological Society (2006).
Dr. Marc Poulin is a Professor of Physiology in the Cumming School of Medicine (Departments of Physiology & Pharmacology, and Clinical Neurosciences). He also holds a joint appointment in the Faculty of Kinesiology, and is a member of the Hotchkiss Brain Institute at the University of Calgary. He holds the Brenda Strafford Foundation Chair in Alzheimer Research. He obtained a Bachelor of Physical and Health Education (Honors) from Laurentian University, an MA and PhD in Exercise Physiology from the University of Western Ontario, and a DPhil in Respiratory and Cerebrovascular Human Physiology from the University of Oxford. His research focuses on the mechanisms of blood regulation in the brain and effects of disturbances in the levels of oxygen and carbon dioxide in the blood in health and disease. His two primary research areas include i) healthy brain aging and dementia (focusing on the impact of exercise on cerebral blood flow and cognitive function), and ii) the effects of intermittent hypoxia in health (using experimental human models), its impact on sleep, cognition and daytime function in high altitude workers, and in the pathogenesis of respiratory-related diseases like obstructive sleep apnea and chronic obstructive pulmonary disease. Dr. Poulin has published over 85 peer-reviewed publications, and his research program is funded by the Canadian Institutes of Health Research (CIHR), the Heart and Stroke Foundation of Canada, and the Natural Science and Engineering Research Council (NSERC) of Canada.
Dr. Martin Prince is Professor of Epidemiological Psychiatry and co-Director of the Centre for Global Mental Health at King’s College London. He trained in Psychiatry at the Maudsley Hospital and in Epidemiology at the London School of Hygiene and Tropical Medicine. His work is oriented to the salience of mental and neurological disorders to health and social policy in low and middle income countries (LMIC), with a focus on ageing and dementia. He has coordinated, since 1998 the 10/66 Dementia Research Group, a network of researchers, mainly from LMIC working together to promote more good research into dementia in those regions.
Dr. Prince was co-author of the Dementia UK report that informed the UK Government’s National Dementia Strategy. He led the development of the widely reported ADI World Alzheimer Reports for 2009 (prevalence and numbers), 2010 (societal cost) and 2011 (early intervention), 2013 (long term care), 2014 (modifiable risk factors), 2015 (update on prevalence, incidence and cost) and was a leading contributor to the WHO World Dementia Report 2012. He coordinated the development of the WHO Mental Health Gap Action Plan (mhGAP) clinical guidelines for dementia care by non-specialists in LMIC.
Dr. Rogalski is Associate Professor and the Director of Neuroimaging for the Cognitive Neurology and Alzheimer’s Disease Center (CNADC) at Northwestern University’s Feinberg School of Medicine. Her research falls under the broad umbrella of aging and dementia and uses a multimodal approach to investigate two aging perspectives: primary progressive aphasia (PPA) in which neurodegenerative disease invades the language network and SuperAging in which individuals are seemingly resistant to the deleterious changes in memory associated with “normal” or more typical cognitive aging. Her investigations assist in defining the clinical and anatomical features of different dementia syndromes as well as identifying genetic and other risk factors. She also develops educational programs, support groups and therapies to improve quality of life for patients with dementia. She has received research support from the National Institutes of Health, the Association for Frontotemporal Degeneration (AFTD), the Alzheimer’s Association and other philanthropic sources.
Dr. Jiri G. Safar is the Director of the National Prion Disease Pathology Surveillance Center (NPDPSC) and Associate Professor in the Departments of Pathology and Neurology at Case Western Reserve University (CWRU). After completing his residency, chief residency, and PhD training in Biochemistry, he received a Research Fellowship in the Laboratory of Central Nervous System Studies at the National Institutes of Health (NIH), directed by D.C. Gajdusek (Nobel Prize for Medicine 1976). In 1996, he took a position as a Senior Scientist at the Institute for Neurodegenerative Diseases, directed by Stanley B. Prusiner (Nobel Prize for Medicine 1997), and Associate Professor at the University of California at San Francisco (UCSF). In 2008, Dr. Safar was recruited to continue his research on neurodegenerative diseases caused by prions and protein misfolding at CWRU. His extensive research has led to the discovery of previously unknown forms of prions and prion diseases, a better understanding of the conformation of prion proteins, the unraveling of the molecular mechanisms of prion strains, and the development of new methods for detection and differentiation of prions and other misfolded proteins. Dr. Safar has authored 116 publications and holds 27 U.S. and international patents.
Dr. Tolu Sajobi is Assistant Professor of Biostatistics in the Departments of Community Health Sciences and Clinical Neurosciences at the University of Calgary. He received his PhD in Biostatistics from the University of Saskatchewan. His research focuses on development and application of biostatistical methods in clinical and population health studies. Specifically, his research program centers on (1) multivariate methods for assessing measurement bias in behavioral and self-reported outcomes studies, (2) robust clinical and population risk prediction models, and (3) design and analysis of randomized controlled trials. His research has been supported by the Canadian Institutes of Health Research and MSI Foundation. Dr. Sajobi provides collaborates and provides biostatistical leadership on a wide variety of national and international research projects, using statistics to address important clinical and/or population health-related research questions.
Dr. Julie A. Schneider is a Professor of Pathology (Neuropathology) and Neurological Sciences at Rush University Medical Center and Rush Alzheimer’s Disease Center. She completed her Neurology training at the University of Chicago and Neuropathology training at Emory University in Atlanta and is board certified in both specialties. Dr. Schneider has fellowship training in the neuropathology of dementia, is certified in Geriatric Neurology, and has a Masters Degree in Clinical Research with a focus in Epidemiology. She is the Associate Director and Neuropathology Core Leader of the Rush Alzheimer’s Disease Center and the senior neuropathologist for the Religious Orders Study, the Rush Memory and Aging Project, and the Rush Minority Aging Research Study. Dr. Schneider has extensive experience with clinical-pathologic epidemiologic studies of aging and dementia and has over 200 peer-reviewed publications and 4 book chapters. Dr. Schneider’s research focuses on pathologic factors in the clinical expression of cognitive and motor decline in aging. Her work specifically focuses on (1) Alzheimer’s and mixed pathologies (2) vascular pathologies and more recently 3) TDP-43 and hippocampal sclerosis pathologies and their role in transitions from normality to AD and other dementias, and motor impairment, and (4) the use of pathologic endophenotypes to link risk factors (eg. genetic, diet and life style, neurobehavioral, and health related), neuroimaging and peripheral biomarkers, and other biochemical/molecular factors to impairment and resilience.
Dr. Seitz is Chair of the Division of Geriatric Psychiatry at Queen’s University and Medical Director of the Seniors Mental Health Program at Providence Care in Kingston, Ontario. He completed his MD at the University of Saskatchewan in 2003 and his psychiatric residency training at Queen’s University. Dr. Seitz completed fellowship training in clinical epidemiology at the University of Toronto and a PhD in Clinical Epidemiology and Health Services Research at the Institute of Health Policy, Management and Evaluation at the University of Toronto. His research has been supported by the Alzheimer Society of Canada, the Alzheimer’s Association, and the Canadian Institutes of Health Research.
Dr. Sexton is a post-doctoral researcher at the Nuffield Department of Clinical Neurosciences, University of Oxford. She graduated from the University of Manchester with BSc Neuroscience in 2006. She then worked as a Research Assistant at the New York State Psychiatric Institute, Columbia University, before moving to Oxford to complete a DPhil in Psychiatry. Her DPhil research used magnetic resonance imaging (MRI) techniques to investigate the role of structural and functional connectivity in late-life depression, bipolar disorder, mild cognitive impairment and Alzheimer's disease. Claire's current work uses MRI techniques to investigate factors that may promote healthy ageing in the brain, including physical activity and sleep.
Dr. Eric Smith is Associate Professor of Neurology, Radiology and Community Health Sciences at the University of Calgary, where he directs the Cognitive Neurosciences Clinic and is a member of the Calgary Stroke Program. He holds the endowed Katthy Taylor Chair in Vascular Dementia at the University of Calgary. Dr. Smith’s research uses neuroimaging to investigate the risk factors for, and consequences of, cerebral small vessel disease in healthy populations and in patients with mild cognitive impairment or cerebral amyloid angiopathy. He has been funded by operating grants from the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC), Alzheimer Society of Canada, U.S. NINDS, and other agencies. He leads the Vascular Cognitive Impairment team of Canada’s national research strategy for dementia, the Canadian Consortium on Neurodegeneration in Aging. He has published more than 200 articles and has a Google Scholar H Index of 60.
Dr. Straus is a Professor in the Department of Medicine at the University of Toronto. She holds a Tier 1 Canada Research Chair in Knowledge Translation and Quality of Care and more than $30 million in peer reviewed research grants as a principal investigator. She has >300 publications, and has supervised >25 graduate students from different disciplines including clinical epidemiology, health informatics and human factors engineering. She is co-PI of KT Canada, a CIHR and CFI funded national, Clinical Research Initiative, PI of KT Canada’s CIHR-funded Strategic Training Initiative in Health Research and PI of a network meta-analysis team grant for the Drug Safety and Effectiveness Network. She is Division Director of Geriatric Medicine at the University of Toronto and Director of the KT Program at the Li Ka Shing Knowledge Institute of St. Michael’s. She has authored three books. Evidence-based medicine: How to practice and teach it is in its fourth edition, and has been published in 9 languages; Knowledge Translation in Health Care, is now in its second edition; and the first edition of Mentorship in Academic Medicine.
Dr. Stys is a neurologist/basic neuroscientist and a world leader in the study of pathophysiological mechanisms of white matter injury. He completed his neurology training at the University of Toronto and a post-doctoral fellowship at Yale. His lab has extensive expertise in electrophysiological recording methods in myelinated axons, as well as advanced imaging techniques including spectral confocal & multiphoton, and coherent anti-Stokes Raman scattering (CARS) microscopy. Dr. Stys’ team discovered several novel injury mechanisms responsible for axo-glial damage in ischemia/trauma that involve glutamate excitotoxicty. More recently, his team has been exploring protein misfolding in neurodegenerative diseases such as Alzheimer’s. Using spectral methods his group is developing biomarkers for early detection. Also, his focus on neurodegeneration has extended to multiple sclerosis, with the suggestion that this disease also begins as a degenerative process with inflammation/auto-immunity secondary reactions to chronic myelin degradation. Insights provided by his laboratory have provided important new mechanistic information for diseases such as multiple sclerosis, brain and spinal cord trauma, Alzheimer’s disease and stroke, where axons, oligodendrocytes and myelin are prominent targets of damage.
Dr. Thambisetty is the Investigator and Chief of the Unit of Clinical & Translational Neuroscience, Laboratory of Behavioural Neuroscience at the National Institute on Aging. He completed his Bachelor of Medicine, Bachelor of Surgery at the University of Calicut in India as well as a Doctorate of Philosophy at the University of Oxford. His research focuses on developing methods for earlier diagnosis, better treatment and understanding the mechanisms underlying increased risk for Alzheimer’s disease. Through this research he applies multi-modal neuroimaging and a variety of protemic/metabolomic approaches for biomarker discovery in Alzheimer’s Disease and age-associated cognitive impairment. At Johns Hopkins Bayview Medical Campus in Baltimore he evaluates, manages and cares for patients at the Memory and Alzheimer’s Treatment Center. Along with over 50 peer-reviewed publications he is also the recipient of two Outstanding Contribution awards for translational clinical research in aging.
Dr. Voss is an Assistant Professor in the Department of Psychological and Brain Sciences at the University of Iowa. She earned her PhD in Psychology with a focus on Cognitive Neuroscience at the University of Illinois in 2011. At Iowa, in addition to teaching undergraduate and graduate students, she directs the Health, Brain, and Cognition Laboratory. The lab investigates the effects of interventions, such as physical activity, exercise, and cognitive engagement, on brain health and performance, to help understand what steps can be taken to keep people's minds functioning well as they age. This research is also hoping to uncover solutions to help the brain adapt to age-related neurological diseases and brain injury. The foundation for these overarching goals is an interest in advancing knowledge about the basic mechanisms of cognitive aging and brain plasticity, and optimizing methods for measuring structural and functional brain systems in humans. Dr. Voss wrote the following Huffington Post blog article outlining the research aims: “Why It Should Always Be the Season for Exercise.”
Dr. Yaffe is a Professor of Psychiatry, Neurology and Epidemiology, the Roy and Marie Scola Endowed Chair and Vice Chair of Research in Psychiatry at UCSF. She is also the Chief of Neuropsychiatry and Director of the Memory Evaluation Clinic at the San Francisco Veterans Affairs Medical Center. Dr. Yaffe serves on the Beeson Scientific Advisory Committee, the Council of the German Center for Neurodegenerative Diseases, and Alzheimer's Association Medical & Scientific Advisory Council. As the current principal investigator of 7 NIH grants as well as several other DOD and foundation grants, Dr. Yaffe's research focuses on the epidemiology of cognitive aging and late life depression. She was recognized as one of Thomas Reuters World’s Most Influential Scientific Minds in 2014, and she has been honored by the American Association for Geriatric Psychiatry with the Distinguished Scientist Award as well as by the American College of Psychiatrists with the Award for Research in Geriatric Psychiatry.